Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil.

Autor: Tsuchiya, C.T.1, Kim, H.S.J.1, Maximo, M.F.M.1, Ramos, L.A.1
Zdroj: Value in Health. Nov2014, Vol. 17 Issue 7, pA641-A641. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: